[HTML][HTML] PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application

P Xia, XY Xu - American journal of cancer research, 2015 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess unique self-
renewal activity and mediate tumor initiation and propagation. The PI3K/Akt/mTOR signaling …

Understanding cancer stem cell heterogeneity and plasticity

DG Tang - Cell research, 2012 - nature.com
Heterogeneity is an omnipresent feature of mammalian cells in vitro and in vivo. It has been
recently realized that even mouse and human embryonic stem cells under the best culture …

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer …

J Deng, X Bai, X Feng, J Ni, J Beretov, P Graham, Y Li - BMC cancer, 2019 - Springer
Background Ovarian cancer is the most common malignant tumor of the female reproductive
tract. Chemoresistance is a major challenge for current ovarian cancer therapy. However …

Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil

Z Lei, IB Tan, K Das, N Deng, H Zouridis, S Pattison… - Gastroenterology, 2013 - Elsevier
Background & Aims Almost all gastric cancers are adenocarcinomas, which have
considerable heterogeneity among patients. We sought to identify subtypes of gastric …

PTEN tumor-suppressor: the dam of stemness in cancer

F Luongo, F Colonna, F Calapà, S Vitale, ME Fiori… - Cancers, 2019 - mdpi.com
PTEN is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or
variation in PTEN gene/protein levels is commonly observed in a broad spectrum of human …

Current treatment strategies for inhibiting mTOR in cancer

F Chiarini, C Evangelisti, JA McCubrey… - Trends in …, 2015 - cell.com
Mammalian target of rapamycin (mTOR) is a Ser/Thr kinase that regulates a wide range of
functions, including cell growth, proliferation, survival, autophagy, metabolism, and …

Anticancer activity of curcumin and its analogues: preclinical and clinical studies

A Allegra, V Innao, S Russo, D Gerace… - Cancer …, 2017 - Taylor & Francis
Curcumin has been shown to have a wide variety of therapeutic effects, ranging from anti-
inflammatory, chemopreventive, anti-proliferative, and anti-metastatic. This review provides …

Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer

RL Bitting, AJ Armstrong - Endocrine-related cancer, 2013 - erc.bioscientifica.com
Prostate and breast cancer are the two cancers with the highest incidence in men and
women, respectively. Here, we focus on the known biology of acquired resistance to …

Aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells

M Cojoc, C Peitzsch, I Kurth, F Trautmann… - Cancer research, 2015 - AACR
Radiotherapy is a curative treatment option in prostate cancer. Nevertheless, patients with
high-risk prostate cancer are prone to relapse. Identification of the predictive biomarkers and …

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

M Cojoc, C Peitzsch, F Trautmann… - OncoTargets and …, 2013 - Taylor & Francis
The chemokine CXCL12 (SDF-1) and its cell surface receptor CXCR4 were first identified as
regulators of lymphocyte trafficking to the bone marrow. Soon after, the CXCL12/CXCR4 …